RNA modification landscape of the human mitochondrial tRNA<sup>Lys</sup> regulates protein synthesis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30262910.
- Also identified by DOI 10.1038/s41467-018-06471-z and PMC identifier 6160436.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Post-transcriptional RNA modifications play a critical role in the pathogenesis of human mitochondrial disorders, but the mechanisms by which specific modifications affect mitochondrial protein synthesis remain poorly understood. Here we used a quantitative RNA sequencing approach to investigate, at nucleotide resolution, the stoichiometry and methyl modifications of the entire mitochondrial tRNA pool, and establish the relevance to human disease. We discovered that a N<sup>1</sup>-methyladenosine (m<sup>1</sup>A) modification is missing at position 58 in the mitochondrial tRNA<sup>Lys</sup> of patients with the mitochondrial DNA mutation m.8344 A > G associated with MERRF (myoclonus epilepsy, ragged-red fibers). By restoring the modification on the mitochondrial tRNA<sup>Lys</sup>, we demonstrated the importance of the m<sup>1</sup>A58 to translation elongation and the stability of selected nascent chains. Our data indicates regulation of post-transcriptional modifications on mitochondrial tRNAs is finely tuned for the control of mitochondrial gene expression. Collectively, our findings provide novel insight into the regulation of mitochondrial tRNAs and reveal greater complexity to the molecular pathogenesis of MERRF.
Medical subject headings
- Mitochondria
- Protein Biosynthesis
- RNA, Transfer, Lys